|
I-Flow Corporation - Sales Analysis Snapshot
Business Description
This Report provides a comprehensive Sales & Margin summary analysis for I-Flow Corporation Tabular results include up to a ten-year history on Sales, EBITDA (Earnings before Interest, Taxes, Depreciation and Amortization), Income before Extraordinary Items and number of Employees. Additional ratios are included for sales growth, earnings and income as a percent of sales and Sales per Employee.
I-Flow Corporation. The Group's principal activities are to design, develop, manufacture and market technically advanced and low-cost ambulatory infusion systems. It operates in single operating segment, the Company has identified two product lines : Regional Anesthesia & IV Infusion Therapy. It manufactures compact, portable infusion pumps, catheters and pain kits that administer local anesthetic, chemotherapy, nutritional supplement and other medications. The customers of the Group include Hospitals and alternate site settings. It markets its products through its distributors in United States, Canada, Europe, Asia, Mexico, Brazil, Australia, New Zealand and the Middle East. The product line includes the ON-Q (R) Post-Operative Pain Relief System, PainBuster (R) Pain Management System and C-bloc (TM) Continuous Nerve Block System. The Group operates in United States, Europe and Pacific Rim.
Not the Report you are looking for? Click here for more browsing options.
Layout and Content of a Typical Report
|
